Quick Nav
Publications
Pharmacy Times
Continuing Education

Addressing Methamphetamine Abuse at the Pharmacy Counter

Shilpa Amara, PharmD
Published Online: Monday, September 16, 2013   [ Request Print ]

This activity is supported by an educational grant from Acura Pharmaceuticals Inc.

Addressing Methamphetamine Abuse at the Pharmacy Counter

Shilpa Amara, PharmD
Drug Information Specialist
Barnabas Health
South Plainfield, New Jersey



Disclosures

The following contributors have no relevant financial relationships with commercial interests to disclose.

Faculty
Shilpa Amara, PharmD

Pharmacy Times Office of Continuing Professional Education

Planning Staff
Judy V. Lum, MPA, and Steve Lin, PharmD

Pharmacy Times Editorial Staff
Kirk McKay and David Allikas

An anonymous peer reviewer was part of the content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.



Educational Objectives
 
Upon completion of the educational activity, the participant should be able to:
  1. Discuss the origins of methamphetamine abuse and its health and economic toll.
  2. Examine the current status of methamphetamine abuse following implementation of legal restrictions on purchasing of implicated OTC drugs.
  3. Identify further efforts taken to minimize use of OTC drugs for manufacture of methamphetamine.
  4. Identify pharmacy implications associated with use of OTC products in methamphetamine production.
Target audience:   Pharmacists
Type of activity:   Knowledge
Release date:   September 13, 2013
Expiration date:   September 13, 2015
Estimated time to complete activity:   2 hours
Fee:   Free

Click here to view this activity.




Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-257-0701

Copyright HCPLive 2006-2013
Intellisphere, LLC. All Rights Reserved.
 




Become a Member
Forgot Password?